
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Surgery, University of Florida, Gainesville, FL;
2 Department of Surgery and
3 Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and
4 Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL
Requests for reprints: William G. Cance, Health Science Center, University of Florida, P. O. Box 100286, 1600 SW Archer Road, Gainesville, FL 32610-0286. Phone: (352) 265-0622; Fax: (352) 338-9809. E-mail: cance{at}surgery.ufl.edu
Focal adhesion kinase (FAK) and Src have been shown to be overexpressed in colon cancer. We have studied the role of these two kinases in resistance to apoptosis. Adenovirus-containing FAK-CD (Ad-FAK-CD), a dominant-negative, COOH-terminal portion of FAK, was used to inhibit FAK and cause apoptosis. Colon cancer cell lines were more resistant to Ad-FAK-CD-induced detachment and apoptosis than the breast cancer cell line, BT474. Colon cancer cell lines overexpressed highly active Src and FAK. Ad-FAK-CD-induced apoptosis was significantly increased by PP2, an inhibitor of Src family kinases. Activation of caspase-3, down-regulation of FAK, and Src and AKT activities were demonstrated in Ad-FAK-CD + PP2-treated colon cancer cells undergoing apoptosis. The results suggest that FAK and Src are both important survival factors, playing a role in protecting colon cancer cell lines from Ad-FAK-CD-induced apoptosis. Dual inhibition of these kinases may be important for therapies designed to enhance the apoptosis in colon cancers.
This article has been cited by other articles:
![]() |
W. Liu, D. A. Bloom, W. G. Cance, E. V. Kurenova, V. M. Golubovskaya, and S. N. Hochwald FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells Carcinogenesis, June 1, 2008; 29(6): 1096 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Beierle, N. A. Massoll, J. Hartwich, E. V. Kurenova, V. M. Golubovskaya, W. G. Cance, P. McGrady, and W. B. London Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses Clin. Cancer Res., June 1, 2008; 14(11): 3299 - 3305. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Spreafico, S. Schenone, T. Serchi, M. Orlandini, A. Angelucci, D. Magrini, G. Bernardini, G. Collodel, A. Di Stefano, C. Tintori, et al. Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells FASEB J, May 1, 2008; 22(5): 1560 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Pallandre, E. Brillard, G. Crehange, A. Radlovic, J.-P. Remy-Martin, P. Saas, P.-S. Rohrlich, X. Pivot, X. Ling, P. Tiberghien, et al. Role of STAT3 in CD4+CD25+FOXP3+ Regulatory Lymphocyte Generation: Implications in Graft-versus-Host Disease and Antitumor Immunity J. Immunol., December 1, 2007; 179(11): 7593 - 7604. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Beierle, A. Trujillo, A. Nagaram, E. V. Kurenova, R. Finch, X. Ma, J. Vella, W. G. Cance, and V. M. Golubovskaya N-MYC Regulates Focal Adhesion Kinase Expression in Human Neuroblastoma J. Biol. Chem., April 27, 2007; 282(17): 12503 - 12516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazzone and P. M. Comoglio The Met pathway: master switch and drug target in cancer progression FASEB J, August 1, 2006; 20(10): 1611 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Garces, E. V. Kurenova, V. M. Golubovskaya, and W. G. Cance Vascular Endothelial Growth Factor Receptor-3 and Focal Adhesion Kinase Bind and Suppress Apoptosis in Breast Cancer Cells Cancer Res., February 1, 2006; 66(3): 1446 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Golubovskaya, R. Finch, and W. G. Cance Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53 J. Biol. Chem., July 1, 2005; 280(26): 25008 - 25021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Fan, R. O. Jacamo, X. Jiang, J. Sinnett-Smith, and E. Rozengurt G Protein-coupled Receptor Activation Rapidly Stimulates Focal Adhesion Kinase Phosphorylation at Ser-843: MEDIATION BY Ca2+, CALMODULIN, AND Ca2+/CALMODULIN-DEPENDENT KINASE II J. Biol. Chem., June 24, 2005; 280(25): 24212 - 24220. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, H. Lu, P. Dazin, and Y. Kapila Squamous Cell Carcinoma Cell Aggregates Escape Suspension-induced, p53-mediated Anoikis: FIBRONECTIN AND INTEGRIN {alpha}v MEDIATE SURVIVAL SIGNALS THROUGH FOCAL ADHESION KINASE J. Biol. Chem., November 12, 2004; 279(46): 48342 - 48349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Westhoff, B. Serrels, V. J. Fincham, M. C. Frame, and N. O. Carragher Src-Mediated Phosphorylation of Focal Adhesion Kinase Couples Actin and Adhesion Dynamics to Survival Signaling Mol. Cell. Biol., September 15, 2004; 24(18): 8113 - 8133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Duxbury, H. Ito, S. W. Ashley, and E. E. Whang CEACAM6 Cross-linking Induces Caveolin-1-dependent, Src-mediated Focal Adhesion Kinase Phosphorylation in BxPC3 Pancreatic Adenocarcinoma Cells J. Biol. Chem., May 28, 2004; 279(22): 23176 - 23182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |